• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Connect Biopharma Holdings Limited

Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors
July 22, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq
July 21, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference
July 18, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
July 17, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China
July 09, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
June 13, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
June 03, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma to Present at Two Upcoming Investor Conferences in June
May 28, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Presents Data Supporting Development of Rademikibart at the American Thoracic Society (ATS) 2025 International Conference
May 20, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update
May 15, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD
May 14, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
May 13, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference
April 24, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart
April 01, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-Severe Uncontrolled Asthma
March 31, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Reports 2024 Full-Year Financial Results and Provides Business Update
March 31, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
March 28, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma to Present at Two Upcoming Investor Conferences
March 03, 2025
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024
September 10, 2024
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
September 05, 2024
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum
July 01, 2024
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 12, 2024
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Announces New Leadership and Chair of the Board of Directors
June 12, 2024
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB GRI
Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma
May 22, 2024
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
May 07, 2024
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
April 16, 2024
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual Conference
March 19, 2024
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors
February 12, 2024
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
December 12, 2023
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Connect Biopharma to Announce Top-Line Data from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma on December 12, 2023
December 11, 2023
From Connect Biopharma Holdings Limited
Via GlobeNewswire
Tickers CNTB
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap